Events
-
iCare at European Society of Endocrinology (ESE) 2025
We are pleased to announce that we will be attending the European Society of Endocrinology (ESE) from May 10-13, 2025 in Copenhagen! ESE is one of the leading events for endocrinology professionals, offering an incredible opportunity to explore the latest research, innovations, and treatments. We are excited to be part of this global gathering and […]
-
iCare at EAsDEC 2025
We’re thrilled to announce that we will be attending EAsDEC 2025 from June 5-7, 2025 in Liverpool, UK! EAsDEC is a premier event focused on advancements in diabetes and endocrinology care, bringing together leading professionals from around the world. We are excited to showcase our latest innovations and connect with experts in the field. uring […]
Latest news
-
March 28, 2025U.S. FDA cleared the new iCare MAIA microperimeter
Revenio Group Corporation | Press Release | March 28, 2025 at 09:00:00 EET Icare, a subsidiary of Revenio Group, has today announced that the U.S. Food and Drug Administration (FDA) has cleared the new iCare MAIA microperimeter. This clearance marks a significant milestone in our growth and innovation strategy, aimed at better meeting market diagnostic […]
-
December 18, 2024iCare MAIA®: A new level of excellence in microperimetry
iCare, a subsidiary of Revenio Group, has today announced updates on the release of the new version of the iCare MAIA® microperimeter. The new iCare MAIA® microperimeter which retains all the key features that made it the gold standard in microperimetry, is currently in the final stages of preparation. We are pleased to confirm that […]
- August 23, 2024 iCare ST500™: A New Era in slit-lamp tonometry
- August 20, 2024 Icare Finland Oy has acquired Thirona Retina B.V.
- July 12, 2021 iCare will attend the ESCRS congress in Amsterdam on October 8-10
- March 16, 2021 The new iCare HOME2 self-tonometer enables easy and accurate eye pressure measurement by glaucoma patients